Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  10, 816 - 820 (2004)
Published online: 4 July 2004; | doi:10.1038/nm1076

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia

Haibin Xia1, 2, 8, Qinwen Mao1, 2, 8, Steven L Eliason1, 2, Scott Q Harper1, 2, Inês H Martins1, 2, Harry T Orr3, 4, Henry L Paulson5, Linda Yang6, Robert M Kotin6 & Beverly L Davidson1, 2, 5, 7

1  Program in Gene Therapy, University of Iowa, Iowa City, Iowa, USA.

2  Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.

3  Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

4  Institute of Human Genetics, University of Minnesota, Minneapolis, Minnesota, USA.

5  Department of Neurology, University of Iowa, Iowa City, Iowa, USA.

6  National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

7  Department of Physiology & Biophysics, University of Iowa, Iowa City, Iowa, USA.

8  These authors contributed equally to this work.

Correspondence should be addressed to Beverly L Davidson beverly-davidson@uiowa.edu
The dominant polyglutamine expansion diseases, which include spinocerebellar ataxia type 1 (SCA1) and Huntington disease, are progressive, untreatable, neurodegenerative disorders. In inducible mouse models of SCA1 and Huntington disease, repression of mutant allele expression improves disease phenotypes. Thus, therapies designed to inhibit expression of the mutant gene would be beneficial. Here we evaluate the ability of RNA interference (RNAi) to inhibit polyglutamine-induced neurodegeneration caused by mutant ataxin-1 in a mouse model of SCA1. Upon intracerebellar injection, recombinant adeno-associated virus (AAV) vectors expressing short hairpin RNAs profoundly improved motor coordination, restored cerebellar morphology and resolved characteristic ataxin-1 inclusions in Purkinje cells of SCA1 mice. Our data demonstrate in vivo the potential use of RNAi as therapy for dominant neurodegenerative disease.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

RNAi quashes polyQ

Nature Medicine News and Views (01 Aug 2004)

Research Highlights

Nature Biotechnology News and Views (01 Aug 2004)

See all 9 matches for News And Views
 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

  • Mitigating Zinc Corrosion

    • Deadline: Aug 23 2009
    • Reward: $20,000 USD

    The Seeker is looking for novel methods to mitigate zinc corrosion/gassing in alkaline media. This ...

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
See also: News and Views by Caplen
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy